Graphite. Source: Adobe Images
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Multi-mineral developer Walkabout Resources Ltd (ASX:WKT) has produced and shipped its first consignment of graphite concentrate to customers in Europe from Tanzanian graphite mine Lindi Jumbo.

The on-specification concentrate was bagged in May and shipped as Walkabout continues carrying out commissioning work at Lindi Jumbo, with this work focused on boosting plant performance, availability and utilisation.

The company is also hoping to capitalise on the United States’s announcement of tariffs on Chinese graphite, which is expected to improve pricing of the product.

Walkabout’s managing director and CEO Andrew Cunningham said the company had achieved an important goal with the shipping announcement.

“The successful production of on-spec, saleable product during the commissioning process at the Lindi Jumbo plant facility is an exciting milestone,” he said.

“To achieve our first concentrate shipment from site, at a time when customers are looking to shore up their graphite supply chains is a rewarding and outstanding outcome for the tenacity of our people, community, contractors and shareholders.

“We now have the opportunity to engage with more end-users as we continue to demonstrate we have a viable product and that we are serious contenders in development of non-Chinese graphite supply.”

Walkabout has been trading at 12 cents.

WKT by the numbers
More From The Market Online
Organised crime concept

Panic, paranoia, and gangland politics: HotCopper users react to Dubber’s missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due…
The Market Online Video

ASX Market Update: Bourse nears record approaching week’s end | November 22, 2024

The bourse is near record territory to close out the week on the back of a…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…